Breast milk drug study withdrawn before start
NCT ID NCT06181630
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to measure how much of the drug ozanimod passes into breast milk and to check for any effects on breastfed infants. It planned to include lactating women already taking ozanimod for medical reasons. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREASTFED INFANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Las Vegas Clinical Research Unit
Las Vegas, Nevada, 89113-2228, United States